Innovation for Life

Developing Innovative drugs, Biosimilars, Platforms, and Diagnostic technologies to improve lives.

Advancing Antibody Science

Advancing antibody drugs and biosimilars to address unmet medical needs.

Creating Value for a Healthier Life

Improving patient access through cost-effective, high-quality biosimilars.

PRESTIGE BIOPHARMA

PRESTIGE BIOPHARMA IDC

PRESTIGE BIOLOGICS

7

Beyond technological discovery, expanding access to care for patients around the world

Innovative Drug

Development of First-in-Class therapeutics for unmet diseases

Biosimilar

Prominent Biosimilars pipelines for accelerating market access

Platform Technology

A drug delivery platform that enhances treatment convenience

Diagnostics

Diagnostics for Pancreatic cancer by detecting PAUF

Prestige News

Total 64
Number Thumbnail Title Author Date Votes Views
54 Prestige Biopharma IDC Files Patent for Next-Generation Antibody Delivery Platform ‘IDC224’
김** | 2026.04.21 | Votes 0 | Views 950
김** 2026.04.21 0 950
53 BJFEZ Advances Open Innovation Campus for AI-Driven Drug Development
김** | 2026.04.13 | Votes 0 | Views 675
김** 2026.04.13 0 675
52 Prestige Biopharma's Avastin Biosimilar HD204 Nears Regulatory Approval and Commercialization
김** | 2026.03.24 | Votes 0 | Views 1111
김** 2026.03.24 0 1111
51 Prestige Biopharma IDC Signs Strategic Research Collaboration Agreement with Pusan National University Medical Research Institu
김** | 2026.02.25 | Votes 0 | Views 547
김** 2026.02.25 0 547
50 Prestige Biopharma IDC Files Patent for Bispecific Antibody Targeting Cytokine Storm–Related Inflammatory Diseases
김** | 2026.02.24 | Votes 0 | Views 545
김** 2026.02.24 0 545
49 Prestige Biopharma IDC Obtains ISO 9001 Certification for Global Quality Management System
김** | 2026.01.29 | Votes 0 | Views 422
김** 2026.01.29 0 422
48 Prestige Biopharma IDC Files Patent for PBP1710 Targeting Fibrotic Diseases
김** | 2026.01.23 | Votes 0 | Views 468
김** 2026.01.23 0 468
47 Prestige Biopharma Secures U.S. Patent for Novel Anticancer Antibody PBP1710
김** | 2025.12.08 | Votes 0 | Views 415
김** 2025.12.08 0 415
46 Prestige Biopharma IDC Selected for National Drug Development Project for TNBC Program
김** | 2025.11.25 | Votes 0 | Views 499
김** 2025.11.25 0 499
45 Prestige Biopharma Secures Herceptin Biosimilar Supply Deal in South America
김** | 2025.11.24 | Votes 0 | Views 509
김** 2025.11.24 0 509

Read Prestige news >>